Considerations in scale-up of viral vaccine production

BioProcess International

Volumn 9, Issue SUPPL. 8, 2011, Pages 16-28

  Whitford, William G ^a   Fairbank, Alain ^b  

^a Thermo Fisher Scientific   (United States)

^b AF Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

BIOPROCESS; BIOTECHNOLOGY; CELL LINE; CULTURE MEDIUM; DISPOSABLE EQUIPMENT; DRUG DESIGN; LARGE SCALE PRODUCTION; MICROCARRIER CULTURE; NONHUMAN; PRODUCT SAFETY; REVIEW; SCALE UP; STIRRED REACTOR; VACCINE PRODUCTION; VIRUS REPLICATION;

EID: 84857598048     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Review

References (21)

1. Cima G. Rinderpest Eradicated: International Organizations Declare "Cattle Plague" Dead. J. Am. Vet. Med. Assoc. 239(1) 2011: 12-15; www.avma.org/onlnews/javma/jul11/110701a.asp.
2. Whitford W. Using Disposables in Cell-Culture-Based Vaccine Production. BioProcess Int. 8(4) 2010: S20-S27.
3. Pincus S. Webinar: Modern Vaccine and Adjuvant Production and Characterization. Genetic Eng. News 27 April 2011; www.genengnews.com/webinars/ modern-vaccine-and-adjuvant-production-and-characterization/136.
4. Abe K, et al. Serum-Free Cell Culture System Supplemented with Lipid-rich Albumin for Hepatitis C Virus (strain O of genotype 1b) Replication. Virus Res. 125(2) 2007: 162-168. (Pubitemid 46589677)
5. Sabahi A. Hepatitis C Virus Entry: The Early Steps in the Viral Replication Cycle. Virology J. 6, 2009: 117.
6. Bertram JL, et al. Vaccinia Virus Vaccines: Past, Present, and Future. Antiviral Res. 84(1) 2009: 1-13.
7. Whitford W. How Much QbD for Raw Materials and Excipients: Small Molecules and Biologics Issues. ISPE Brussels Meeting on Risk-Based Control Strategies in Pharmaceutical Industries, Brussels, Belgium. ISPE: Tampa, FL, 22 September 2010.
8. 21 CFR 876.5885. Tissue Culture Media for Human Ex Vivo Tissue and Cell Culture Processing Applications. US Fed. Reg. (66)95, 2001: 27025-27026; www.gpo.gov/fdsys/pkg/FR-2001-05-16/pdf/01-12238.pdf
9. CBER. Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications. US Food and Drug Administration: Rockville, MD, February 2010; www.fda.gov/downloads/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/guidances/vaccines/ucm202439.pdf.
10. Code of Federal Regulations, Title 21, Part 610. US Food and Drug Administration: Rockville, MD, 20 November 1973 - 1 April 2010; www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=610.
11. Microcarriers Introduction. SoloHill Engineering, Inc.: Ann Arbor, MI, 2011; www.solohill.com/Solohill/Microcarriers/Microcarriers-Introduction.
12. Elias C. A Hybrid Single-Use Bioreactor for Scale-Up of Virus Vaccine Production Using Duck Cell Lines. IBC's Second Annual International Forum Vaccine Production Summit, Boston, MA. IBC Life Sciences: Westborough, MA, 6-8 June 2011.
13. Whitford W. Single-Use Systems as Principal Components in Bioproduction. BioProcess Int. 8(11) 2010: 34-42.
14. Eibl D, Peuker T, Eibl R. Single-Use Equipment in Biopharmaceutical Manufacture: A Brief Introduction. Single-Use Technology in Biopharmaceutical Manufacture. Eibl R, Eibl D, Eds. John Wiley & Sons, Inc.: Hoboken, NJ, January 2011.
15. Hirschel M, et al. Novel Uses for Hollow Fiber Bioreactors: Application in Influenza Virus Production. Genetic Eng. News. 31(12) 2011; www.genengnews.com/gen-articles/novel-uses-for-.hollow-fiber-bioreactors/3700.
16. Aldridge S. Mobile Vaccine Factories. Nat. Biotechnol. 29 February 2011: 99.
17. Whitford B. Single-Use Systems Support of PAT and QbD in Bioproduction. Life Sci. Leader 2(12) 2010: 36-38.
18. CDER/CBER/CVM. Guidance for Industry: Process Validation - General Principles and Practices. US Food and Drug Administration: Rockville, MD, January 2011; www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070336.pdf.
19. Cappuccino N. ICH Q11: Development and Manufacture of Drug Substances Guideline Update. JAPM/USP and Middle East/North Africa (MENA) Stakeholders Sixth Science and Standards Symposium Exploring the Latest Advances and Trends in Standards and Regulations. Session IV: Quality of Manufactured Medicines - Part One, October 2010; www.usp.org/pdf/EN/meetings/workshops/ mENA6thStakeholdersSymposiumJORDANDay2.pdf.
20. Doceul V, et al. Repulsion of Superinfecting Virions: A Mechanism for Rapid Virus Spread. Science 327(5967) 2010: 873-876.
21. McSharry JJ, Drusano GL. Antiviral Pharmacodynamics in Hollow Fibre Bioreactors. Antivir. Chem. Chemother. 21(5) 2011: 183-192.